VRTX
Vertex Pharmaceuticals Inc
526.20$
+0.7%
vs. previous close
Closing price · As of: Sep 25, 2026
Statements
Income Statement
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | 1996 | 1997 | 1998 | 1999 | 2000 | 2001 | 2002 | 2003 | 2004 | 2005 | 2006 | 2007 | 2008 | 2009 | 2010 | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| – | +229.3% | +1.4% | +38.7% | +26.8% | +114.4% | -3.8% | -57.1% | +48.6% | +56.6% | +34.5% | -8.0% | -11.8% | -41.9% | +40.5% | +883.9% | +8.3% | -20.6% | -52.1% | +77.9% | +64.9% | +46.2% | +22.5% | +36.6% | +49.1% | +22.1% | +17.9% | +10.5% | +11.7% | +9.6% | |
| – | – | – | – | – | +870.8% | -28.6% | -88.9% | +80.7% | +78.8% | +20.5% | +14.2% | +12.8% | -9.5% | -10.4% | +532.4% | +247.7% | -53.5% | -53.2% | +105.9% | +67.6% | +30.7% | +48.9% | +33.7% | +34.4% | +22.8% | +19.5% | +16.8% | +21.3% | +18.1% | |
| – | +187.3% | +3.2% | +32.9% | +13.9% | +72.7% | +3.9% | -50.3% | +47.0% | +55.3% | +35.4% | -9.3% | -13.7% | -45.0% | +48.7% | +918.2% | -6.2% | -13.3% | -52.0% | +74.6% | +64.5% | +48.4% | +19.2% | +37.0% | +51.3% | +22.0% | +17.7% | +9.6% | +10.3% | +8.2% | |
| – | +46.6% | +13.8% | +23.0% | +17.6% | +75.1% | +36.6% | -1.7% | -3.7% | +29.3% | +49.6% | +38.0% | +0.6% | +6.7% | +15.7% | +11.0% | +13.9% | +14.0% | -6.9% | +16.4% | +5.2% | +26.4% | +6.9% | +23.9% | +4.3% | +66.8% | -13.0% | +19.1% | +14.8% | +3.4% | |
| – | +44.3% | +58.8% | +44.2% | +6.5% | +70.2% | +4.3% | -20.9% | +7.8% | +4.4% | +31.5% | +46.4% | +20.3% | +27.8% | +44.2% | +113.4% | -5.6% | -9.4% | -15.6% | +21.9% | +13.9% | +23.6% | +12.4% | +18.1% | +17.0% | +9.0% | +5.6% | +28.1% | +28.8% | +19.7% | |
| – | +43.8% | +22.1% | +28.7% | +7.8% | +73.9% | +28.8% | -5.4% | -1.9% | +24.9% | +46.8% | +39.2% | +3.4% | +10.0% | +21.4% | +34.3% | +12.1% | +3.1% | -9.4% | +18.3% | +7.8% | +23.0% | +8.4% | +22.2% | +8.3% | +48.9% | -8.9% | +34.8% | +103.6% | -43.4% | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | -98.0% | -38,841.3% | – | – | – | +1,140.4% | +415.4% | +88.5% | +138.5% | -2.6% | +54.8% | -11.0% | -106.1% | – | |
| – | – | – | – | – | – | – | – | – | – | – | -100.0% | – | -2.1% | +46.1% | +89.7% | -54.5% | +36.5% | +220.6% | +15.6% | -3.3% | -14.9% | -50.8% | +71.5% | -0.6% | +5.8% | -10.9% | -19.5% | -30.6% | -56.5% | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | -120.5% | – | – | – | – | – | – | +132.4% | +123.4% | -12.4% | +55.0% | +3.5% | -94.3% | +1,768.5% | |
| – | -94.1% | +16.7% | +100.0% | -30.3% | -296.3% | – | – | +20.6% | +112.6% | -130.0% | – | – | – | -0.3% | 0.0% | +101.2% | -844.6% | – | +336.6% | -45.1% | -744.0% | – | – | +85.8% | -4.2% | +134.5% | -16.5% | +3.1% | -12.0% | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | -461.9% | – | – | – | – | – | +695.8% | -43.9% | +130.4% | -13.6% | +41.8% | +9.0% | -114.8% | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | -68.3% | -1,406.4% | – | – | – | +36.8% | +584.5% | +120.8% | +110.5% | -11.2% | +52.0% | +3.8% | -89.4% | +900.1% |
Data as of: September 25, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.